Picture 1 of 2
Stock photo
Picture 1 of 2
Stock photo
Introduction to Market Access for Pharmaceuticals by Mondher Toumi (2017, Trade Paperback)
Global Dispatch (7098)
92.7% positive feedback
Price:
$163.00
Free shipping
Returns:
60 days returns. Buyer pays for return shipping. If you use an eBay shipping label, it will be deducted from your refund amount.
Condition:
The first guide to market access for pharmaceuticals based on tested teaching materials. Explains the impact the changing healthcare market will have on your product.
- Buy It NowIntroduction to Market Access for Pharmaceuticals by Mondher Toumi
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
About this product
Product Identifiers
PublisherTaylor & Francis Group
ISBN-101138032182
ISBN-139781138032187
eBay Product ID (ePID)228633077
Product Key Features
Number of Pages204 Pages
LanguageEnglish
Publication NameIntroduction to Market Access for Pharmaceuticals
Publication Year2017
SubjectMarketing / General, Pharmacy, Industries / Pharmaceutical & Biotechnology, Pharmacology, Chemistry / General
TypeTextbook
Subject AreaScience, Business & Economics, Medical
AuthorMondher Toumi
FormatTrade Paperback
Dimensions
Item Height0.5 in
Item Weight17.3 Oz
Item Length10.9 in
Item Width8.4 in
Additional Product Features
Intended AudienceCollege Audience
LCCN2016-026978
Dewey Edition23
IllustratedYes
Dewey Decimal615.10688
Table Of ContentChapter 1: Health as a Good Chapter 2: Decision-Making in Public Health Chapter 3: Definition and Concepts Chapter 4: HTA Decision Analysis framework Chapter 5: Early HTA Advice Chapter 6: Overview of Market Access Agreements Chapter 7: External Reference Pricing Chapter 8: Gap between Payers and Regulators Chapter 9: Early Access Programs Chapter 10: Market Access of Orphan Drugs Chapter 11: Market Access of Vaccines in Developed Countries Chapter 12: France Chapter 13: Germany Chapter 14: Italy Chapter 15: Spain Chapter 16: Sweden Chapter 17: United Kingdom Chapter 18: The United States Chapter 19: Japan Chapter 20: China
SynopsisMarket access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers' needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University. Key Features: The first guide to market access for pharmaceuticals based on tested teaching materials Addresses both pharmaceutical and vaccine products Includes case studies and scenarios Covers market access consdierations for Western Europe, the USA, Japan and China Explains the impact the changing healthcare market will have on your product, Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers' needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.
LC Classification NumberHF5439.D75
All listings for this product
Be the first to write a review
